HiperScan secures $0.60 million in funding - MarketLine Financial Deals

HiperScan secures $0.60 million in funding

HiperScan secures $0.60 million in funding - MarketLine Financial Deals
HiperScan secures $0.60 million in funding
Published Nov 06, 2013
3 pages — Published Nov 06, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

HiperScan GmbH, a Germany-based developer of scanning grating technology, has secured EUR0.45 million ($0.60 million) in funding from HCS Beteiligungsgesellschaft mbH, High-Tech Grunderfonds Management GmbH and Technologiegrunderfonds Sachsen.

  
Source:
Document ID
MA143683_131211
Country
Country
Ticker
FFGO=US
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "HiperScan secures $0.60 million in funding" Nov 06, 2013. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/HiperScan-secures-0-60-million-in-funding-2052-99338>
  
APA:
MarketLine Financial Deals. (2013). HiperScan secures $0.60 million in funding Nov 06, 2013. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/HiperScan-secures-0-60-million-in-funding-2052-99338>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.